Abbott Labs announced earnings per share of $1.4 on revenue of $10.93B. Analysts polled by Investing.com anticipated EPS of $0.9442 on revenue of $9.55B.
Abbott Labs shares are up 9% from the beginning of the year, still down 7.99% from its 52 week high of $129.70 set on September 13. They are under-performing the S&P 500 which is up 20.33% from the start of the year.
Abbott Labs shares gained 3.07% in pre-market trade following the report.
Abbott Labs’s report follows an earnings beat by J&J on Tuesday, who reported EPS of $2.6 on revenue of $23.34B, compared to forecasts EPS of $2.36 on revenue of $23.66B.
Intuitive Surgical had beat expectations on Tuesday with third quarter EPS of $1.19 on revenue of $1.4B, compared to forecast for EPS of $1.17 on revenue of $1.39B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar